[Tuberculosis lupus after BCG vaccination. A rare complication of the vaccination].
BACKGROUND
Cutaneous reactions to BCG have rarely been a problem and BCG is one of the safest vaccines in use.


METHODS
Two children, 6 and 7 years old, developed local tuberculosis lupus 7 and 8 months, respectively, after BCG vaccination. Cutaneous changes cured after a treatment with isoniazid for 9 months in one case with observance of the treatment was uncertain in the other.


CONCLUSIONS
Tuberculosis lupus is a rare complication of BCG vaccination. Its clinical features are identical to those of the vulgaris lupus. The diagnosis is based on clinical, pathology aspects and anamnesia. This complication should not be a contra-indication of BCG immunization.
Vittori
F
F
Département de médecine polyvalente, hôpital Saint-Jean-de-Dieu, Lyon, France.
Groslafeige
C
C
D000995:Antitubercular Agents / Q000627:therapeutic use; D001500:BCG Vaccine / Q000009:adverse effects*; D002648:Child; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D008178:Lupus Erythematosus, Cutaneous / Q000188:drug therapy / Q000209:etiology*
D000995:Antitubercular Agents; D001500:BCG Vaccine; D007538:Isoniazid
Le lupus tuberculeux post-BCG. Une complication rare de la vaccination.